Presutti Dario, Agarwal Tarun, Zarepour Atefeh, Celikkin Nehar, Hooshmand Sara, Nayak Chinmay, Ghomi Matineh, Zarrabi Ali, Costantini Marco, Behera Birendra, Maiti Tapas Kumar
Institute of Physical Chemistry, Polish Academy of Sciences, 01-224 Warsaw, Poland.
Department of Biotechnology, Indian Institute of Technology, Kharagpur 721302, West Bengal, India.
Materials (Basel). 2022 Jan 4;15(1):337. doi: 10.3390/ma15010337.
Nanozymes, a type of nanomaterial with enzyme-like properties, are a promising alternative to natural enzymes. In particular, transition metal dichalcogenides (TMDCs, with the general formula MX, where M represents a transition metal and X is a chalcogen element)-based nanozymes have demonstrated exceptional potential in the healthcare and diagnostic sectors. TMDCs have different enzymatic properties due to their unique nano-architecture, high surface area, and semiconducting properties with tunable band gaps. Furthermore, the compatibility of TMDCs with various chemical or physical modification strategies provide a simple and scalable way to engineer and control their enzymatic activity. Here, we discuss recent advances made with TMDC-based nanozymes for biosensing and therapeutic applications. We also discuss their synthesis strategies, various enzymatic properties, current challenges, and the outlook for future developments in this field.
纳米酶是一类具有类酶性质的纳米材料,是天然酶的一种有前景的替代品。特别是,基于过渡金属二硫属化物(TMDCs,通式为MX,其中M代表过渡金属,X是硫属元素)的纳米酶在医疗保健和诊断领域已展现出非凡的潜力。由于其独特的纳米结构、高表面积以及具有可调带隙的半导体性质,TMDCs具有不同的酶促性质。此外,TMDCs与各种化学或物理修饰策略的兼容性为设计和控制其酶活性提供了一种简单且可扩展的方法。在此,我们讨论基于TMDC的纳米酶在生物传感和治疗应用方面的最新进展。我们还讨论了它们的合成策略、各种酶促性质、当前面临的挑战以及该领域未来发展的前景。